Evidence brief · Supplement

Agmatine for Exercise performance

Evidence grade D — No real human data

Overall grade
Grade D
Last revised
1
graded outcome
0
references listed

Assembled by the app from other entries in this library. It adds no evidence of its own — follow the links to the entries it draws on.

1 at grade D — 1 graded row

What is known

Each outcome with its grade (how strong the evidence is, A to D), the size of the effect where the entry records one, and how often studies agree.

  • Exercise performanceEvidence grade D

    No real human data

    Unclearlow

What is uncertain

Read off the same rows as above. Nothing here is added that the entry does not itself record.

  • Thin evidence: Exercise performance (grade D).

The evidence in words

The verdict

For exercise performance, Agmatine earns evidence grade D (unclear effect, low consistency) — the evidence does not support the claim. No real human data

How it might work

It modulates nitric-oxide synthase and several receptors (NMDA, imidazoline); human relevance is unestablished.

How to use it

500–1,000 mg pre-workout if trialing; evidence is thin.

Safety & cautions

Limited human safety data; generally tolerated short-term.

Bottom line

Trendy in pre-workouts, thin on human evidence. Skip for proven ingredients.

How it is used

As the entry records it, from the studies it summarises. Not a recommendation for you — doses that suit a trial population may not suit you.

If trialing
500–1,000 mg pre-workout.

Goes with

  • AgmatineRead the full Agmatine monographEvidence grade D

Entries that share this one's tags or conditions.

Sources

This entry lists no references of its own — it is assembled from the entries it links to, whose sources are on their pages.

Last revised . A grade is this entry's reading of the evidence, not medical advice.